METHIMAZOLE TABLETS USP DIN 02489732
Status: Cancelled Pre Market
Holder: ENDO OPERATIONS LTD.
Health Canada record
| Active ingredient(s) | METHIMAZOLE 20 MG |
|---|
| Dosage form | Tablet |
|---|
| Route | Oral |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Human |
|---|
| ATC | H03BB02 THIAMAZOLE |
|---|
| Original market date | |
|---|
| Current status date | 07-Jul-2023 |
|---|
| Source | Health Canada DPD |
|---|
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing METHIMAZOLE
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02411512 | FELIMAZOLE 1.25 MG | DECHRA LTD | Tablet | METHIMAZOLE 1.25 MG | Marketed |
| 02332655 | FELIMAZOLE 2.5MG | DECHRA LTD | Tablet | METHIMAZOLE 2.5 MG | Marketed |
| 02332663 | FELIMAZOLE 5MG | DECHRA LTD | Tablet | METHIMAZOLE 5 MG | Marketed |
| 02490633 | JAMP METHIMAZOLE | JAMP PHARMA CORPORATION | Tablet | METHIMAZOLE 10 MG | Marketed |
| 02490625 | JAMP METHIMAZOLE | JAMP PHARMA CORPORATION | Tablet | METHIMAZOLE 5 MG | Marketed |
| 02480115 | MAR-METHIMAZOLE | MARCAN PHARMACEUTICALS INC | Tablet | METHIMAZOLE 10 MG | Marketed |
| 02480107 | MAR-METHIMAZOLE | MARCAN PHARMACEUTICALS INC | Tablet | METHIMAZOLE 5 MG | Marketed |
| 02258935 | APO-METHIMAZOLE | APOTEX INC | Tablet | METHIMAZOLE 5 MG | Dormant |
| 02265869 | DOM-METHIMAZOLE | DOMINION PHARMACAL | Tablet | METHIMAZOLE 5 MG | Cancelled Pre Market |
| 02489716 | METHIMAZOLE TABLETS USP | ENDO OPERATIONS LTD. | Tablet | METHIMAZOLE 5 MG | Cancelled Pre Market |
| 02489724 | METHIMAZOLE TABLETS USP | ENDO OPERATIONS LTD. | Tablet | METHIMAZOLE 10 MG | Cancelled Pre Market |
| 02265850 | PHL-METHIMAZOLE | PHARMEL INC | Tablet | METHIMAZOLE 5 MG | Cancelled Pre Market |
| 02244323 | PMS-METHIMAZOLE | PHARMASCIENCE INC | Tablet | METHIMAZOLE 5 MG | Cancelled Post Market |
| 02296047 | TAPAZOLE | PALADIN PHARMA INC. | Tablet | METHIMAZOLE 20 MG | Cancelled Pre Market |
| 02296039 | TAPAZOLE | KNIGHT THERAPEUTICS INC. | Tablet | METHIMAZOLE 10 MG | Cancelled Post Market |
| 00015741 | TAPAZOLE | KNIGHT THERAPEUTICS INC. | Tablet | METHIMAZOLE 5 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 22323 | 2019-06-25 | New Drug Submission (NDS) | Administrative: Licensing Agreement between two companies and updates to the Product Monograph and Bottle Labels |
International API supply for METHIMAZOLE
6 active FDA Drug Master Files.
Request a quote for METHIMAZOLE TABLETS USP
How to read a Canadian DIN record